AbbVie Inc (ABBV) is reportedly negotiating to buy Gilgamesh Pharmaceuticals, a private company focusing on mental health treatments, for roughly $1 billion. The discussions, highlighted by Bloomberg, ...

AbbVie already has a working relationship with Gilgamesh, in the form of an R&D collaboration and opt-in licensing agreement ...

Blowout results from megacaps Microsoft and Meta catapulted U.S. stock futures up more than 1% on Thursday, while an ...

Cloud revenue at Microsoft rises 27% in the software giant’s fiscal fourth quarter, while second-quarter revenue at Meta ...

Over at Microsoft, its fiscal fourth-quarter earnings per share surged 24% to $3.65, beating the consensus estimate of $3.37, with Cloud revenue up 27% and Intelligent Cloud up 26%, with CEO Satya ...